1. The Role of Branched-Chain Amino Acid Supplementation in Combination with Locoregional Treatments for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis
   Georgios A. Sideris et al, 2023, Cancers CrossRef
2. Dietary management and supplementation with branched-chain amino acids in cirrhosis of the liver
   A. Ruiz-Margáin et al, 2018, Revista de Gastroenterología de México (English Edition) CrossRef
3. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma
   Simona Cernea et al, 2023, World Journal of Gastroenterology CrossRef
4. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: Chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched‐chain amino acids
   Masahito Shimizu et al, 2014, Molecular Nutrition & Food Research CrossRef
5. Obesity and Hepatocarcinogenesis
   Yoshio Sumida et al, 2019, Alcoholic/Non-Alcoholic Digestive Diseases CrossRef
6. Systematic review with meta‐analysis: Branched‐chain amino acid supplementation in liver disease
   Anne M. van Dijk et al, 2023, European Journal of Clinical Investigation CrossRef
7. Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis
   Ling Chen et al, 2015, Nutrition Journal CrossRef
8. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
   Fereshteh Asgharzadeh et al, 2020, Current Pharmaceutical Design CrossRef
9. The effect of branched-chain amino acid supplementation on cancer treatment
   Kassidy Lee et al, 2023, Nutrition and Health CrossRef
10. Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment
    Saori Kamachi et al, 2016, Hepatology Research CrossRef
11. The mechanism of branched-chain amino acid transferases in different diseases: Research progress and future prospects
    Xiazhen Nong et al, 2022, Frontiers in Oncology CrossRef
12. A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment
    Yuko Takami et al, 2016, Hepatology International CrossRef
13. Manejo dietético y suplementación con aminoácidos de cadena ramificada en cirrosis hepática
    A. Ruiz-Margáin et al, 2018, Revista de Gastroenterología de México CrossRef
14. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function
    Taro Takami et al, 2016, World Journal of Gastroenterology CrossRef
15. Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives
    Emanuele Rinninella et al, 2017, Journal of Clinical and Translational Hepatology CrossRef
16. New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
    Hankil Lee et al, 2022, Clinical and Translational Gastroenterology CrossRef